Ladenburg Thalmann Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $30
Buy Rating for Achieve Life Sciences on Cytisinicline's Promise in Nicotine Addiction Treatment
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Lake Street Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $11
Achieve Life Sciences (ACHV) Gets a Buy From Lake Street
JonesTrading Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
Achieve Life Sciences (ACHV) Receives a Buy From Lake Street
Buy Rating Affirmed: Achieve Life Sciences' Promising Path to Cytisinicline NDA and Strong Financial Outlook
Buy Rating Affirmed for Achieve Life Sciences Amid Positive Drug Development Progress and Strong Financial Position
Achieve Life Sciences Analyst Ratings
Buy Rating Affirmed for Achieve Life Sciences on Strong Clinical Progress and Solid Financial Footing
Achieve Life Sciences Analyst Ratings
Achieve Life Sciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Phathom Pharmaceuticals (PHAT)
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), ClearPoint Neuro (CLPT)
Achieve Life Sciences Analyst Ratings
Buy Rating for Achieve Life Sciences on Cytisinicline's Promising Future and Solid Financials
Oppenheimer Maintains Outperform on Achieve Life Sciences, Lowers Price Target to $18
Achieve Life Sciences Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vor Biopharma (VOR), Gilead Sciences (GILD) and Achieve Life Sciences (ACHV)